Drug Eluting Stent Market, By Coating (Polymer-based coatings, Polymer-free coatings, and Others), By Application (Peripheral Artery Disease, Coronary Artery Disease, and Others), By End-Users (Hospitals, Ambulatory Surgical Centers, Cardiology Centers, and Specialty Clinics) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Report Code: PMI496422 | Publish Date: May 2024 | No. of Pages: 180

Drug Eluting Stent Market Overview

Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of 6.5%.

The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.

In the current research scope 2021 is considered as base year and 2022 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2022 to 2032. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.

FAQs

The Drug Eluting Stent Market is segmented into coating, application, end-users, and region.

Drug Eluting Stent Market is driven by factors like rise in cardiovascular diseases, rate of urbanization, and technological advancement.

By region, the Drug Eluting Stent market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.

The key players operating the Drug Eluting Stent Market includes, Abbott, Cook Medical, Medtronic, Biotronik, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Meril Life Sciences, Wellinq, B. Braun Melsungen AG, Biosensors International Group Limited, and others.